Beyond Verbal is committed to identifying proprietary Vocal Biomarkers for personalized healthcare screening & monitoring based on your own voice. The Vocal Biomarker engine analyzes free speech using a proprietary speaker diarization tool to provide non-intrusive, continuous and scalable information on people health. Our early clinical findings demonstrated that by using BIG DATA, AI machine learning and deep learning techniques, we can predict and monitor chronic diseases and human emotions. Availability, high compliance and non-invasiveness of voice enable early screening, real time alerting and remote monitoring of various health conditions, such as cardiovascular (CAD and CHF), COPD, diabetes, sleep apnea, and others.
Sleep Pioneers.
Beacon Biosignals is now the owner of the Dreem 3S EEG device and R&D business. Sunrise is now the owner of the Dreem Health digital sleep clinic.
MindMaze is a global leader in digital neuro-therapeutics (DTx) solutions with a mission to accelerate the brain's ability to recover, learn and adapt. With over a decade of work at the intersection of neuroscience, bio-sensing, engineering, mixed reality and artificial intelligence, its healthcare division is addressing some of the most challenging problems in neurology, including stroke, Alzheimer disease and Parkinson disease, by creating the universal platform for brain health and recovery and unique digital therapeutic interventions. MindMaze's pioneering FDA cleared and CE marked neuro-digital therapeutics accelerate patients' recovery from many critical neurological conditions. Founded in 2012 by CEO Dr Tej Tadi, MindMaze is the first Swiss Unicorn with offices in Lausanne, Baltimore, London, Paris and Mumbai.